Palavra-chave: CML

PIOGLITAZONE HMGCLL1 PREGNANCY CHRONIC MYELOID LEUKAEMIA NILOTINIBE PEDIATRIC PATIENTS BCR-ABL MULTICENTER STUDY SURVIVAL SARS-COV-2 BCR/ABL GENE EDI-PIO LOW EDUCATION LEVEL FIRST LINE TERAPHY CARDIOVASCULAR EVENTS ALLOGENEIC BONE MARROW ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION DISCONTINUATION TRIAL PERIPHERAL BLOOD STEM CELLS TRANSPLANTATION BRAZIL PATIENTS IN BRAZIL 2022 CHRONIC MYELOID LEUKEMIA TKI CYTOGENETIC REMISSION GENERIC IMATINIB BCR/ABL GENE SEPT5 TFR BCR-ABL1 IMATINIB COMORBIDITIES STEM CELL TRANSPLANTATION HOCT1 PBSC CHRONIC PHASE CHILDREN AND ADOLESCENTS D-HPLC DASATINIB NON-MYELOABLATIVE NILOTINIB BCR-ABL MUTATIONS F359V TYROSINE KINASE INHIBITORS BONE MARROW TRANSPLANTATION WHO DASATINIBE THIRD-LINE TKI TREATMENT CARDIOVASCULAR ENACT CARDIOVASCULAR RISK